Search clinical trials for: Adrenergic Agonists

Total 16303 results

Uptown Eye Specialists

Completed

Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery

Cataract Surgery | Subconjunctival Hemorrhage

Canada
Allergan

Terminated

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON)

Macular Degeneration | Geographic Atrophy

United States, Italy, United Kingdom, Germany, Australia, France
Catalan Institute of Health

Completed

Effectiveness of a Structured Intervention to Optimize the Use of Mirabegron

Overactive Bladder Syndrome
Isfahan University of Medical Sciences

Completed

Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia

Pregnant Women With Mild Preeclampsia
Forest Laboratories

Completed

A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients

Hypertension

United States, Puerto Rico
Research Foundation for Mental Hygiene, Inc.
Icahn School of Medicine at Mount Sinai; Bronx VA Medical Center

Unknown

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia (Guanfacine)

Schizophrenia | Schizoaffective Disorder | Cognitive Impairment

United States
Walter Reed Army Medical Center

Unknown

Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

Ocular Hypertension | Glaucoma

United States
Icahn School of Medicine at Mount Sinai

Completed

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Syncope

United States
University of Alberta
Alberta Health services; Institute of Health Economics, Canada; University Hospital...

Recruiting

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

Vasoplegia

Canada
Shire

Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
Ingrid Jazet

Unknown

Mirabegron and Brown Adipose Tissue (Mirab)

Obesity

Netherlands
The Cleveland Clinic
American College of Gastroenterology

Withdrawn

Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis

End Stage Liver Disease | Cirrhosis | Ascites | Hypotension

United States
Berlin-Chemie Menarini

Completed

Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol (ENESYS)

Primary Arterial Hypertension

Romania
National Center for Research Resources (NCRR)
Roberts Pharmaceutical

Completed

Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension

Orthostatic Hypotension

United States
University of Alabama at Birmingham

Completed

Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) (PTNS-M)

Overactive Bladder

United States
University of Colorado, Denver
Juvenile Diabetes Research Foundation

Completed

Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
Massachusetts General Hospital
Sir Charles Gairdner Hospital

Completed

Midodrine for the Treatment of Refractory Hypotension

Critical Illness | Hypotension

United States, Australia
Yale University
VA Office of Research and Development

Completed

The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects (GuaKet)

NMDA Receptor Function

United States
Eye Therapies, LLC

Completed

Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

Ocular Redness

United States
Seoul National University Hospital

Unknown

Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma

Normal Tension Glaucoma

Korea, Republic of
Milton S. Hershey Medical Center

Terminated

Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine

Airway Remodeling

United States
Genovate Biotechnology Co., Ltd.,
Allergan Medical

Unknown

Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy

Glaucoma

Taiwan
Northwell Health

Completed

Dobutamine on the Cardiac Conduction System

Arrhythmias, Cardiac

United States
University of British Columbia

Completed

Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury

Orthostatic Intolerance

Canada
Lawson Health Research Institute

Terminated

Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients

Urinary Bladder, Neurogenic

Canada
Northwell Health

Withdrawn

Midodrine During Recovery From Septic Shock

Sepsis | Shock, Septic | Hypotension
Fundacion para la Investigacion Biomedica del Hospital...
University of Pecs; Institut National de la Santé Et de la Recherche Médicale... and other collaborators

Terminated

Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period (NeoCirc-001)

Shock

Spain
Brighton and Sussex University Hospitals NHS Trust
European Union

Completed

NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy

Circulatory Failure

United Kingdom
University of Chicago
Forest Laboratories

Withdrawn

Safety Study of Nebivolol for COPD Patients

High Blood Pressure

United States
Erling Bjerregaard Pedersen

Completed

The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension (NEBI)

Essential Hypertension

Denmark
Astellas Pharma Europe B.V.

Completed

A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

Healthy Subjects | Pharmacokinetics of YM178

Netherlands
Allergan

Completed

24-hour IOP-lowering Effect of Brimonidine 0.1%

Ocular Hypertension | Open-angle Glaucoma

United States
Norgine

Completed

Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

Fecal Incontinence

United Kingdom
Noha Mansour

Recruiting

Midodrine Effect on the Mortality Rates in Septic Shock Patients

Septic Shock

Egypt
Shachi Tyagi
National Institute on Aging (NIA)

Recruiting

Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women (SLAB)

Nocturia | Urgency Urinary Incontinence

United States
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Refractory Ascites in Children With Cirrhosis

India
Federal University of Paraíba

Completed

Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial

Hypertension | Pregnancy-Induced Hypertension in Postpartum | Postpartum Pre-Eclampsia

Brazil
Genuine Research Center, Egypt
Multi-Apex Pharma

Completed

Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)

Healthy

Egypt
Yale University
National Institute of Mental Health (NIMH); Massachusetts General Hospital; University... and other collaborators

Completed

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Pervasive Development Disorders

United States
Ain Shams University

Completed

Impact of Midodrine Administration on the Clinical Outcome of Septic Shock Patients

Septic Shock

Egypt
University of Avignon

Completed

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Diabetes-related Complications

France
Icahn School of Medicine at Mount Sinai

Completed

Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD

ADHD | Attention Deficit Hyperactivity Disorder

United States
Rigshospitalet, Denmark

Completed

Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty

Postoperative Orthostatic Hypotension | Postoperative Orthostatic Intolerance

Denmark
Radboud University Medical Center

Unknown

Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia

Preeclampsia

Netherlands
Hvidovre University Hospital

Completed

DOCICAR: Cardiac Dysfunction in Cirrhosis

Cirrhosis | Cirrhotic Cardiomyopathy

Denmark
Mayo Clinic

Not yet recruiting

Use of Midodrine in Septic Shock Patients

Sepsis | Low Blood Pressure

United States
Steen Hvitfeldt Poulsen

Recruiting

Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) (DobATTR)

ATTR Amyloidosis Wild Type

Denmark
Federal University of São Paulo

Not yet recruiting

Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. (DEEP)

Sepsis | Hypoperfusion | Hyperlactatemia

Brazil
University Hospital, Limoges
Centre d'Investigation Clinique 1415

Recruiting

Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion (ADAPT)

Sepsis | Cardiomyopathies | Hypoperfusion | Left Ventricular Systolic Dysfunction

France

Search clinical trials for: Adrenergic Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations